In the current study, we set to investigate the association between circulating autoantibodies to adrenergic, muscarinic, endothelin receptor type A (ETA), and AT1 receptors and specific clinical manifestations of depression, cognitive impairment including memory disorders, and sleep disturbances in symptomatic women with SBIs. This evidence concerns the gene EDNRA and depressive symptom measurement.